Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 11

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis

Total article views   Abstract views HTML views PDF downloads Totals
6,258 Dovepress* 4,403 805+ 1,260 5,208
PubMed Central* 0 1,050 483 1,050
Totals 4,403 1,855 1,743 6,258
*Since 27 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar